Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2022-05-09 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁成大股份有限公司第十届董事会第十二次（临时）会议决议公告
Transaction in Own Shares Classification · 95% confidence The document is a formal announcement of the resolutions passed at a board meeting of 辽宁成大股份有限公司 regarding a share repurchase plan. It details the board's approval of a proposal to repurchase shares via centralized bidding for the purpose of an equity incentive plan, including specifics on the repurchase method, funds, and authorization for the board to handle related matters. The document is not a full financial report, earnings release, or regulatory filing but a specific announcement about the company's share buyback plan approved by the board. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company announcements about buying back its own shares. The document length is about 2055 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is POS with high confidence.
2022-05-09 Chinese
辽宁成大股份有限公司关于董事长提议回购公司股份的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from the company's board regarding a proposal by the chairman to repurchase company shares. It details the reasons, purpose, amount, pricing principles, and procedural steps for the proposed share buyback. There is no financial statement or comprehensive financial data presented, nor is it a report or presentation. The document is a formal announcement about a capital action (share repurchase). According to the filing definitions, announcements about share repurchases fall under 'Transaction in Own Shares' (POS). The document length is short and focused solely on the share repurchase proposal, confirming it is not a full report but an announcement of a capital transaction.
2022-05-09 Chinese
辽宁成大股份有限公司关于召开2021年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2021 Annual General Meeting (AGM) of 辽宁成大股份有限公司, including the date, voting methods, agenda items, and proxy forms. It lists the specific proposals to be voted on, such as the 2021 annual report, financial statements, profit distribution, amendments to company bylaws, and share repurchase plans. The document does not contain the actual annual report or financial statements but rather the notification and procedural details for the AGM. The length is about 4565 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2022-05-09 Chinese
辽宁恒信律师事务所关于辽宁成大股份有限公司以集中竞价交易方式回购公司股份之法律意见书
Transaction in Own Shares Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and compliance of a company's share repurchase plan via centralized bidding. It discusses the approval process, legal compliance with company law, securities law, stock exchange listing rules, and specific share repurchase regulations. The document does not contain financial statements or earnings data but focuses on the legal aspects of the share repurchase. This type of document is a legal opinion related to a share repurchase transaction, which aligns with the category of Transaction in Own Shares (POS). It is not an announcement of the repurchase, nor a financial report, but a legal opinion supporting the repurchase transaction.
2022-05-09 Chinese
辽宁成大股份有限公司关于以集中竞价交易方式回购公司股份方案的公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement regarding a company's plan to repurchase its own shares through centralized bidding transactions. It includes specifics about the purpose of the repurchase (for an equity incentive plan), the type and amount of shares to be repurchased, the price limits, funding sources, implementation period, risks, and authorizations. It also discusses the impact on the company's financials and governance, and includes independent directors' opinions. The document is not a financial report, earnings release, or management discussion, but rather a formal announcement of a share repurchase plan. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company announcements about buying back or selling its own shares (share repurchase/issuance). The document length is sufficient and contains substantive details about the repurchase plan, not just a brief notice or a report publication announcement.
2022-05-09 Chinese
辽宁成大股份有限公司独立董事关于第十届董事会第十二次（临时）会议相关事项的独立意见
Transaction in Own Shares Classification · 95% confidence The document is an independent directors' opinion on a share repurchase plan by the company. It discusses the legality, necessity, and impact of the share buyback, referencing relevant laws and company governance rules. It does not contain financial statements or detailed financial data but rather an opinion on a specific capital action (share repurchase). This fits the category of a Transaction in Own Shares (POS) report, which covers company buyback or sale of its own shares.
2022-05-09 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.